Complaint
Product Indications
1)Acute myeloid leukemia: Whether be used alone or in combination with other antineoplastic drugs, daunorubicin is indicated for the treatment of various tumor staging of acute myeloid leukemia; it is also indicated for the treatment of promyelocytic leukemia.
2)Acute lymphocytic leukemia: Although daunorubicin has a high remission rate for the treatment of acute lymphocytic leukemia, but because of its serious side effects and there are other effective therapeutic methods available, daunorubicin is only applied to those cases that have become resistant to other drugs. Co-administration of daunorubicin hydrochloride with prednisone and vincristine has been proven to be very successful in the acute phase of acute lymphocytic leukemia.
3)Other tumors: Daunorubicin showed a good effect on the treatment of neuroblastoma and rhabdomyosarcoma.
Detailed Photos
Company Profile
Our Advantages
The group built up a long technology partnership with more than 100 institutes and universities at home and abroad meanwhile it enhances its own independent innovation system. Lunan Enterprise Technology center's technology innovative ability ranks the forefront in Pharmaceutical industry and got the title"Top Ten Best Industrial Enterprises of Domestic Pharmaceutical R & D Product Line".
